Clinical Research Directory
Browse clinical research sites, groups, and studies.
AATD-Liver Scan Study
Sponsor: Alpha-1 Foundation
Summary
The goal of this study is to provide liver stiffness screenings (FibroScans) to patients with Alpha-1 Antitrypsin Deficiency for the following purposes: To evaluate the prevalence of elevated liver stiffness among homozygous and heterozygous individuals who carry mutations in the SERPINA1 gene. To assess whether the coexistence of metabolic or environmental cofactors, such as obesity, diabetes, alcohol use, or hepatic steatosis, modifies the risk of liver fibrosis among those with alpha 1 antitrypsin deficiency.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
1000
Start Date
2026-01-27
Completion Date
2030-01-01
Last Updated
2026-10-27
Healthy Volunteers
No
Conditions
Locations (1)
Alpha-1 Foundation
Coral Gables, Florida, United States